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Background
DNA methylation at vertebrate promoters is associated
with the repression of gene expression and is required
for mammalian development [1]. The master genome
regulator and transcription factor CTCF canonically
exhibits methylation-sensitive binding in vitro, and its
in vivo occupancy across cell types anticorrelates with
methylation at 41 % of sites genome-wide [2]. However,
the genome harbors hundreds of thousands of CTCF
recognition sequences, the majority of which are
unbound in any cell type. Although most unbound
recognition sequences harbor methylation in a given cell
type, the causal role of DNA methylation in the abroga-
tion of transcription factor binding at these potential
binding sites is largely unknown [3,4].
Materials and methods
Here we perform genome-wide occupancy profiling after
both stable genetic and transient chemical inhibition of
DNA methyltransferases in HCT116 cells lacking func-
tional DNMT1 and DNMT3b and K562 erythroleukemia
cells treated with 5-aza-2-deoxycytidine.
Results
We show that the vast majority of susceptible binding sites
remain unoccupied upon depletion of DNA methylation.
Stable loss of methylation in HCT116 cells does result in a
minor increase of several thousand binding sites, largely
corresponding to selective reactivation of binding sites
from other cell types, especially from other malignant cell
lines. Chemical inhibition in K562 cells results in a smaller
but reproducible set of several hundred reactivated sites,
the majority of which are corroborated by the genetic
data. The narrow extent of reactivation implies that the
majority of transcription factor recognition sequences are
not competent for binding even in the absence of methyla-
tion, and that methylation accounts for only a modest
fraction of cell-selective binding. These results offer new
insight into the establishment of the global regulatory
landscape, and offer an important perspective on the inter-
pretation of disease- and trait-associated methylation dif-
ferences in humans.
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